Fatal drug overdoses in healthcare workers: A thematic framework analysis of coroner reports
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | Thikra Algahtani, Siobhan Gee, Aminah Shah, Bryn D. Williams, Hayley C. Gorton, Sarah Welch, Caroline S. Copeland |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Characteristics of drug‐related deaths among individuals identified as LGBTQ+ in the United Kingdom, 1997–2024
di: Emmert Roberts, et al.
Pubblicazione: (2025)
di: Emmert Roberts, et al.
Pubblicazione: (2025)
Commentary on Craft et al.: Drug contaminants and substitutions in illicit vapes represent a major health risk
di: Caroline S. Copeland
Pubblicazione: (2025)
di: Caroline S. Copeland
Pubblicazione: (2025)
Characteristics of deaths due to drug‐related causes among individuals recently released from prison in the United Kingdom, 1997–2025
di: Emmert Roberts, et al.
Pubblicazione: (2026)
di: Emmert Roberts, et al.
Pubblicazione: (2026)
Changing trends in drug overdose mortality in Spain, 2001–2022
di: Florencia Giné, et al.
Pubblicazione: (2025)
di: Florencia Giné, et al.
Pubblicazione: (2025)
Differences in heroin overdose risk associated with the unregulated drug market: Insights from a supervised injecting facility in Melbourne, Australia
di: Nathan C. Stam, et al.
Pubblicazione: (2024)
di: Nathan C. Stam, et al.
Pubblicazione: (2024)
Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug‐testing and law enforcement
di: Caroline S. Copeland, et al.
Pubblicazione: (2024)
di: Caroline S. Copeland, et al.
Pubblicazione: (2024)
Brief report: A cross‐sectional survey of provider engagement with family members following patient drug overdose death
di: Jessica B. Calihan, et al.
Pubblicazione: (2026)
di: Jessica B. Calihan, et al.
Pubblicazione: (2026)
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review
di: Philipa Owusu‐Antwi, et al.
Pubblicazione: (2025)
di: Philipa Owusu‐Antwi, et al.
Pubblicazione: (2025)
Impact of enhanced practices on opioid overdose deaths: A community‐based modeling approach
di: Carolina Barbosa, et al.
Pubblicazione: (2026)
di: Carolina Barbosa, et al.
Pubblicazione: (2026)
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–2021
di: Abenaa A. Jones, et al.
Pubblicazione: (2024)
di: Abenaa A. Jones, et al.
Pubblicazione: (2024)
Health care service utilization and drug overdose death: A national nested case–control registry study
di: Linn Gjersing, et al.
Pubblicazione: (2024)
di: Linn Gjersing, et al.
Pubblicazione: (2024)
Qualitative analysis of barriers and facilitators to healthcare engagement for people with injecting‐related invasive infections using a social ecological framework
di: Lucy O. Attwood, et al.
Pubblicazione: (2025)
di: Lucy O. Attwood, et al.
Pubblicazione: (2025)
Predictors of emergency medical transport refusal following opioid overdose in Washington, DC
di: Ben Turley, et al.
Pubblicazione: (2024)
di: Ben Turley, et al.
Pubblicazione: (2024)
A heroin overdose laboratory model: How do escalating doses of diamorphine alter respiratory function in a diamorphine‐treated population?
di: Basak Tas, et al.
Pubblicazione: (2025)
di: Basak Tas, et al.
Pubblicazione: (2025)
Clinical factors linked to xylazine exposure in emergency department patients with illicit opioid overdose
di: Jennifer S. Love, et al.
Pubblicazione: (2026)
di: Jennifer S. Love, et al.
Pubblicazione: (2026)
Clinical characteristics of heroin overdose deaths among older adults in Australia, 2000–2025
di: Shane Darke, et al.
Pubblicazione: (2025)
di: Shane Darke, et al.
Pubblicazione: (2025)
Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference‐in‐differences time series
di: Nathaniel Day, et al.
Pubblicazione: (2026)
di: Nathaniel Day, et al.
Pubblicazione: (2026)
Commentary on Giné et al .: The hidden face of overdose: Gender inequities along the continuum of care
di: Patrizia Carrieri, et al.
Pubblicazione: (2025)
di: Patrizia Carrieri, et al.
Pubblicazione: (2025)
Inequities in naloxone administration among fatal overdose decedents by race and ethnicity in Pennsylvania, 2019–21
di: Erin Takemoto, et al.
Pubblicazione: (2024)
di: Erin Takemoto, et al.
Pubblicazione: (2024)
Commentary on Stam et al .: The substantial and dynamic contribution of opioid potency to total overdose risk
di: Phillip O. Coffin
Pubblicazione: (2024)
di: Phillip O. Coffin
Pubblicazione: (2024)
Use and perceptions of involuntary civil commitment among post‐overdose outreach staff in Massachusetts, United States: A mixed‐methods study
di: Emily R. Cummins, et al.
Pubblicazione: (2024)
di: Emily R. Cummins, et al.
Pubblicazione: (2024)
Cannabis and the overdose crisis among US adolescents
di: Archie Bleyer, et al.
Pubblicazione: (2024)
di: Archie Bleyer, et al.
Pubblicazione: (2024)
Analysis of rapid onset heroin overdose cases from a supervised injecting facility in Melbourne, Australia
di: Nathan C. Stam, et al.
Pubblicazione: (2025)
di: Nathan C. Stam, et al.
Pubblicazione: (2025)
Association between state‐level kratom regulations and poison center‐reported severe medical outcomes and healthcare use: A United States national analysis
di: Grant Comstock, et al.
Pubblicazione: (2026)
di: Grant Comstock, et al.
Pubblicazione: (2026)
Isaac Campos. Home grown: Marijuana and the origins of Mexico's war on drugs
di: Wayne Hall, et al.
Pubblicazione: (2025)
di: Wayne Hall, et al.
Pubblicazione: (2025)
Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type
di: Corey J. Hayes, et al.
Pubblicazione: (2024)
di: Corey J. Hayes, et al.
Pubblicazione: (2024)
Distinguishing chronic disease profiles and cause of death attribution in opioid and or stimulant toxicity deaths to inform overdose prevention efforts
di: Heather Palis, et al.
Pubblicazione: (2026)
di: Heather Palis, et al.
Pubblicazione: (2026)
Response to Crockford et al .: Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference‐in‐differences time series
di: Nathaniel Day, et al.
Pubblicazione: (2026)
di: Nathaniel Day, et al.
Pubblicazione: (2026)
Alcohol and drug use and attainment of pregnancy preferences in the southwestern United States: A longitudinal cohort study
di: Sarah Raifman, et al.
Pubblicazione: (2025)
di: Sarah Raifman, et al.
Pubblicazione: (2025)
A descriptive analysis of rural‐urban overdose experiences among incarcerated women with opioid use disorder
di: Megan F. Dickson, et al.
Pubblicazione: (2025)
di: Megan F. Dickson, et al.
Pubblicazione: (2025)
Heightened mortality risk after a non‐fatal opioid overdose: Risk factors for mortality in the week following emergency treatment
di: Desiree Eide, et al.
Pubblicazione: (2024)
di: Desiree Eide, et al.
Pubblicazione: (2024)
Commentary on Metcalfe et al.: ‘What works in AOD is when it feels like I am driving’ (Craig W, alcohol and drug peer worker)
di: Jeremy S. Hayllar
Pubblicazione: (2024)
di: Jeremy S. Hayllar
Pubblicazione: (2024)
Association between change in alcohol use reported during routine healthcare screening and change in subsequent hospitalization: A retrospective cohort study
di: Helen E. Jack, et al.
Pubblicazione: (2025)
di: Helen E. Jack, et al.
Pubblicazione: (2025)
The effect of proportional pricing on alcohol purchasing in two online experiments
di: Inge Kersbergen, et al.
Pubblicazione: (2024)
di: Inge Kersbergen, et al.
Pubblicazione: (2024)
Craving self‐reports as outcome measures in drug addiction trials: A systematic review of ClinicalTrials.gov
di: Matin Toulami, et al.
Pubblicazione: (2025)
di: Matin Toulami, et al.
Pubblicazione: (2025)
Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: A retrospective cohort study from British Columbia, Canada
di: Samantha Young, et al.
Pubblicazione: (2025)
di: Samantha Young, et al.
Pubblicazione: (2025)
Brief report: Meth, tranq, gas station heroin & other drugs complicating addiction treatment
di: Erin L. Winstanley, et al.
Pubblicazione: (2026)
di: Erin L. Winstanley, et al.
Pubblicazione: (2026)
Predictors of alcohol and other drug treatment completion among young people accessing residential and community‐based treatment: A retrospective analysis of routinely collected service data
di: Megan Wells, et al.
Pubblicazione: (2024)
di: Megan Wells, et al.
Pubblicazione: (2024)
Commentary on Dowd et al .: Beyond single data sources—Consistency checking and evidence synthesis for prevalence estimation
di: Hayley E. Jones, et al.
Pubblicazione: (2026)
di: Hayley E. Jones, et al.
Pubblicazione: (2026)
Associations among social determinants of health and opioid use disorder and overdose: An umbrella review
di: Lauren B. Loeffel, et al.
Pubblicazione: (2026)
di: Lauren B. Loeffel, et al.
Pubblicazione: (2026)
Documenti analoghi
-
Characteristics of drug‐related deaths among individuals identified as LGBTQ+ in the United Kingdom, 1997–2024
di: Emmert Roberts, et al.
Pubblicazione: (2025) -
Commentary on Craft et al.: Drug contaminants and substitutions in illicit vapes represent a major health risk
di: Caroline S. Copeland
Pubblicazione: (2025) -
Characteristics of deaths due to drug‐related causes among individuals recently released from prison in the United Kingdom, 1997–2025
di: Emmert Roberts, et al.
Pubblicazione: (2026) -
Changing trends in drug overdose mortality in Spain, 2001–2022
di: Florencia Giné, et al.
Pubblicazione: (2025) -
Differences in heroin overdose risk associated with the unregulated drug market: Insights from a supervised injecting facility in Melbourne, Australia
di: Nathan C. Stam, et al.
Pubblicazione: (2024)